-
Posted by
Two Blokes Jul 9 -
Filed in
Stock
-
4 views
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST) on behalf of long-term stockholders following a class action complaint that was filed against West on June 20, 2025 with a Class Period from February 16, 2023 and February 12, 2025. Our investigation concerns whether the board of directors of West have breached their fiduciary duties to the company.
